STORY SUMMARY
FDA Launches New Program to Advance Neuroscience Medical Product Development
FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments.
This is a brief summary of reporting from FDA Press Releases. Read the original for the full article and context.